Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer

<p>Abstract</p> <p>Background</p> <p>Despite identification of the major genes and pathways involved in the development of colorectal cancer (CRC), it has become obvious that several steps in these pathways might be bypassed by other as yet unknown genetic events that l...

Full description

Bibliographic Details
Main Authors: Rems Miran, Štor Zdravko, Volavšek Metka, Berginc Gašper, Mlakar Vid, Glavač Damjan
Format: Article
Language:English
Published: BMC 2009-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/282
_version_ 1811279215035678720
author Rems Miran
Štor Zdravko
Volavšek Metka
Berginc Gašper
Mlakar Vid
Glavač Damjan
author_facet Rems Miran
Štor Zdravko
Volavšek Metka
Berginc Gašper
Mlakar Vid
Glavač Damjan
author_sort Rems Miran
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Despite identification of the major genes and pathways involved in the development of colorectal cancer (CRC), it has become obvious that several steps in these pathways might be bypassed by other as yet unknown genetic events that lead towards CRC. Therefore we wanted to improve our understanding of the genetic mechanisms of CRC development.</p> <p>Methods</p> <p>We used microarrays to identify novel genes involved in the development of CRC. Real time PCR was used for mRNA expression as well as to search for chromosomal abnormalities within candidate genes. The correlation between the expression obtained by real time PCR and the presence of the <it>KRAS </it>mutation was investigated.</p> <p>Results</p> <p>We detected significant previously undescribed underexpression in CRC for genes <it>SLC26A3</it>, <it>TPM1 </it>and <it>DCN</it>, with a suggested tumour suppressor role. We also describe the correlation between <it>TPM1 </it>and <it>DCN </it>expression and the presence of <it>KRAS </it>mutations in CRC. When searching for chromosomal abnormalities, we found deletion of the <it>TPM1 </it>gene in one case of CRC, but no deletions of <it>DCN </it>and <it>SLC26A3 </it>were found.</p> <p>Conclusion</p> <p>Our study provides further evidence of decreased mRNA expression of three important tumour suppressor genes in cases of CRC, thus implicating them in the development of this type of cancer. Moreover, we found underexpression of the <it>TPM1 </it>gene in a case of CRCs without <it>KRAS </it>mutations, showing that <it>TPM1 </it>might serve as an alternative path of development of CRC. This downregulation could in some cases be mediated by deletion of the <it>TPM1 </it>gene. On the other hand, the correlation of <it>DCN </it>underexpression with the presence of <it>KRAS </it>mutations suggests that <it>DCN </it>expression is affected by the presence of activating <it>KRAS </it>mutations, lowering the amount of the important tumour suppressor protein decorin.</p>
first_indexed 2024-04-13T00:50:43Z
format Article
id doaj.art-17ddca94bd67414ea8b1400527460b81
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-13T00:50:43Z
publishDate 2009-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-17ddca94bd67414ea8b1400527460b812022-12-22T03:09:53ZengBMCBMC Cancer1471-24072009-08-019128210.1186/1471-2407-9-282Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancerRems MiranŠtor ZdravkoVolavšek MetkaBerginc GašperMlakar VidGlavač Damjan<p>Abstract</p> <p>Background</p> <p>Despite identification of the major genes and pathways involved in the development of colorectal cancer (CRC), it has become obvious that several steps in these pathways might be bypassed by other as yet unknown genetic events that lead towards CRC. Therefore we wanted to improve our understanding of the genetic mechanisms of CRC development.</p> <p>Methods</p> <p>We used microarrays to identify novel genes involved in the development of CRC. Real time PCR was used for mRNA expression as well as to search for chromosomal abnormalities within candidate genes. The correlation between the expression obtained by real time PCR and the presence of the <it>KRAS </it>mutation was investigated.</p> <p>Results</p> <p>We detected significant previously undescribed underexpression in CRC for genes <it>SLC26A3</it>, <it>TPM1 </it>and <it>DCN</it>, with a suggested tumour suppressor role. We also describe the correlation between <it>TPM1 </it>and <it>DCN </it>expression and the presence of <it>KRAS </it>mutations in CRC. When searching for chromosomal abnormalities, we found deletion of the <it>TPM1 </it>gene in one case of CRC, but no deletions of <it>DCN </it>and <it>SLC26A3 </it>were found.</p> <p>Conclusion</p> <p>Our study provides further evidence of decreased mRNA expression of three important tumour suppressor genes in cases of CRC, thus implicating them in the development of this type of cancer. Moreover, we found underexpression of the <it>TPM1 </it>gene in a case of CRCs without <it>KRAS </it>mutations, showing that <it>TPM1 </it>might serve as an alternative path of development of CRC. This downregulation could in some cases be mediated by deletion of the <it>TPM1 </it>gene. On the other hand, the correlation of <it>DCN </it>underexpression with the presence of <it>KRAS </it>mutations suggests that <it>DCN </it>expression is affected by the presence of activating <it>KRAS </it>mutations, lowering the amount of the important tumour suppressor protein decorin.</p>http://www.biomedcentral.com/1471-2407/9/282
spellingShingle Rems Miran
Štor Zdravko
Volavšek Metka
Berginc Gašper
Mlakar Vid
Glavač Damjan
Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
BMC Cancer
title Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
title_full Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
title_fullStr Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
title_full_unstemmed Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
title_short Presence of activating <it>KRAS </it>mutations correlates significantly with expression of tumour suppressor genes <it>DCN </it>and <it>TPM1 </it>in colorectal cancer
title_sort presence of activating it kras it mutations correlates significantly with expression of tumour suppressor genes it dcn it and it tpm1 it in colorectal cancer
url http://www.biomedcentral.com/1471-2407/9/282
work_keys_str_mv AT remsmiran presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer
AT storzdravko presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer
AT volavsekmetka presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer
AT bergincgasper presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer
AT mlakarvid presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer
AT glavacdamjan presenceofactivatingitkrasitmutationscorrelatessignificantlywithexpressionoftumoursuppressorgenesitdcnitandittpm1itincolorectalcancer